Apollo Reaches £4.5 Billion Bond Deal for EDF's UK Nuclear Plant
The bonds will be offered in as many as three tranches, each with a maximum maturity of twelve years, EDF said in statement Friday. The first, for a total of £1.5 billion, will be issued on June 26, while EDF has an option of two other placements in 2026 and 2027.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
18 minutes ago
- Bloomberg
A-List Litigator Alex Spiro Aims at ‘Bigger Business' Than Law
Tom Brady was hardly a surprise as a guest at Jeff Bezos and Lauren Sanchez's star-studded wedding, but the man who accompanied the seven-time Super Bowl champion to the Venice nuptials was a less familiar face to the paparazzi. If lawyer Alex Spiro has his way, that may soon change. With clients like Brady, Elon Musk, WeWork founder Adam Neumann, Jay-Z and Alec Baldwin, among many others, Spiro may have reached the pinnacle of his legal career. But in an extensive interview for The Circuit with Emily Chang, Spiro said he's now looking beyond the courtroom.
Skift
22 minutes ago
- Skift
Event Tech News Roundup: June 2025
As AI sweeps across the event tech landscape, June's developments show a sector racing to redefine value through smarter tools, deeper data, and strategic consolidation. The real winners? Planners who can keep pace with the change. This past month's event tech headlines illustrate a broad spectrum of focus areas. The news covers real-time audience analytics updates, AI-assisted platforms and rebranded AI-centric strategies to name a few. These developments reflect both the maturation and ongoing innovation within the industry. The momentum is clearly toward integrating intelligent automation, enhancing user experiences, and consolidating capabilities across the event lifecycle. While these moves promise greater efficiency, they also point to a more competitive and data-driven future for event tech. Acquisitions LASSO has acquired Shoflo, a provider of run-of-show and teleprompter software, from Cvent. Cvent had acquired Shoflo in August 2021 during its push to expand its offering around virtual event production. Acquiring Shoflo adds live show management capabilities to LASSO, including real-time collaboration and show calling. With the new integration it will focus on what it calls RFP to invoicing capabilities. The platform will offer support for planning, staffing, inventory, and financial management in a single solution. Product Launches Outernet London has launched PIAMS (Public Immersive Audience Measurement System), a real-time visitor analytics tool. The system was developed with spatial analytics specialist Meshh and Virgin Media O2. It uses mobile data and spatial sensors to captures detailed footfall, dwell time, and engagement patterns every five minutes. This enables event organizers and brand partners to measure ROI by aligning audience behavior with specific content and time slots. PCMA has launched Destinaitor, an AI-powered destination and venue research platform developed with dFakto. Previewed at edUcon 2025, the platform uses data provided by Tempest and Simpleview. It covers a wide range of details about venues and destinations, including sustainability, safety, and infrastructure. Access is free for planners, while suppliers can pay to validate their profiles, add data and access analytics. SpeakerStacks is a new platform designed for speakers to capture leads directly from their sessions, without relying on organizers for attendee data. It helps convert speaking engagements into an actionable sales pipeline. Launched in the UK, by industry veteran and co-founder of Event Tech Live Adam Parry, the platform offers branded landing pages accessed via QR codes, GDPR-compliant lead forms, AI-generated follow-ups, CRM integrations, and ROI reporting tools. Visual Hive has launched Erleah, an AI-powered platform offering personalized session and networking recommendations, premium matchmaking placements, and real-time analytics. Delivered as a managed service, it supports year-round community engagement and integrates with existing tech stacks for unified attendee insights. Cvent has introduced CventIQ™, a new AI-powered layer integrated across its event and hospitality platform. Announced at Cvent CONNECT 2025, CventIQ enhances workflows with tools like AI-generated proposals, real-time session sentiment analysis, personalized attendee dashboards, and automated content creation. The platform aims to streamline operations for planners, marketers, and venue professionals through smart automation and tailored insights. Meeting and travel management platform Groupize has rebranded as to showcase a shift to an AI-first strategy. The platform now includes AI-powered modules like DSai for compliance-driven digital sign-in, Marketplace AI for venue sourcing, and Aime, a planning agent. Strategic partnerships with AMGiNE, and MeetingPackage expand its capabilities, including AI-driven air booking and real-time venue availability. Meeting booking platform Hubli has launched EasyPay, a virtual card feature developed with payment provider Conferma. The tool allows corporate event planners to issue virtual cards for each hotel or venue booking, improving payment speed, compliance, and transparency. Integrated into the Hubli platform, EasyPay addresses key payment pain points with automated reconciliation and secure, auditable transactions tailored for meetings and group accommodation. NoteAffect, a note-taking focused event tech tool, has launched event-engage, an AI-powered session engagement platform. The tool enables real-time attendee interaction using session room AV, accessed via QR codes or event apps. Features include AI-driven note-taking, live multilingual captioning, session recordings with summaries, and engagement analytics. Other Event Tech News Gartner's June 2025 Magic Quadrant for Event Marketing and Management Platforms evaluated event management platforms for in-person and virtual B2B events. Gartner classified Bizzabo, Cvent, RainFocus, and vFairs as 'Leaders,' SpotMe as a 'Challenger,' and Swoogo, Stova and EventMobi as 'Niche Players.' The list was considerably different to previous years due to two acquisitions: Brandlive acquired 6Connex and Cvent acquired Splash. Gartner also said it stopped focusing on virtual-first event management platforms (Brandlive, Cisco, Kaltura, RingCentral, Zoom) that featured in previous years. events. Trade show management platform Map Your Show has partnered with NoteAffect to integrate AI-powered session engagement tools into its event management platform. This partnership brings features like interactive note-taking, multilingual captions, searchable recordings, and engagement analytics to trade show sessions.
Yahoo
24 minutes ago
- Yahoo
M.Stanley takes neutral stance on Genmab ahead of portfolio, execution updates
-- Morgan Stanley has begun coverage of Genmab (CSE:GMAB) (NASDAQ:GMAB) with an Equal-Weight rating and a price objective of $24, reduced slightly from the previous $25 target. The Wall Street bank sees limited near-term upside as the most impactful catalysts are expected in 2026. 'Given that particular catalysts poised to most likely re-rate GMAB stock are anticipated to occur in 2026, we assume coverage at EW rating and look toward incremental updates on development timelines and commercial execution over the remainder of 2025,' analyst Judah C. Frommer said. Genmab is navigating a transition away from heavy reliance on Darzalex royalties and focusing more on its proprietary pipeline, particularly Epkinly, Rina-S, and acasunlimab. Following Johnson & Johnson (NYSE:JNJ)'s decision not to opt into the HexaBody-CD38 program, Frommer says attention will shift to maximizing internal pipeline value. For Epkinly, a supplemental BLA has been submitted in 2L+ follicular lymphoma based on the EPCORE-FL-1 study. While top-line data showed the study met one of its co-primary endpoints, progression-free survival data are still pending and expected later this year. More significant Phase III readouts for Epkinly in earlier-line DLBCL are scheduled for 2026. 'In the near-term however, focus remains on current commercial execution strategy in the 3L+ settings for DLBCL and FL as we await key data updates,' Frommer added. Meanwhile, Rina-S is progressing across multiple indications. At American Society of Clinical Oncology (ASCO), data in endometrial cancer showed response rates of 50% and 47% in two dose cohorts. The company plans to initiate a pivotal Phase III trial in 2L+ endometrial cancer in the second half of 2025 and a separate trial in platinum-sensitive ovarian cancer before year-end. Acasunlimab also remains a focus. Morgan Stanley expects updated Phase II data in 2L+ NSCLC later this year. The Phase III trial, which uses overall survival as the primary endpoint, is anticipated to read out in 2027. In sum, though Morgan Stanley views Genmab's management execution and pipeline-building strategy as sound, it sees 2026 as a more realistic timeframe for material stock re-rating. In the meantime, 'we look toward updates on development timelines and commercial execution over the remainder of 2025,' the bank said. Related articles takes neutral stance on Genmab ahead of portfolio, execution updates MS initiates coverage on AI Biotechs, flags key pipeline catalysts Chip stock targets raised at Mizuho following recent rally Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
